Patents by Inventor Fanling Meng

Fanling Meng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230399456
    Abstract: Described are a carbon-iodine conjugated polymer and preparation thereof, an imaging marker thereof, and uses thereof for preparing a localization marker, and belongs to the technical field of imaging markers. The conjugated structure enables the polymer to have strong absorption in a visible light region, and high iodine content of up to 84.1% corresponds to the strong imaging ability thereof. During surgery, on the basis of the dual guidance of a polymer-based image marker and naked eye observation, the marker can better facilitate determination of tumor resection margins, achieving precise resection of tumors and minimizing damage to surrounding normal tissues. During cyberknife-based treatment, the polymer can replace clinical gold markers to provide ray marker guidance.
    Type: Application
    Filed: March 8, 2022
    Publication date: December 14, 2023
    Inventors: Liang LUO, Mingming YIN, Xiaoming LIU, Fanling MENG
  • Publication number: 20140286821
    Abstract: Alloys including iron, nickel, manganese, aluminum and chromium are disclosed. The alloys have high strength and ductility. The alloys are prepared from readily available transition metals, and can be used in applications where properties similar to steel are necessary or advantageous.
    Type: Application
    Filed: March 21, 2014
    Publication date: September 25, 2014
    Applicant: The Trustees of Dartmouth College
    Inventors: Ian Baker, Fanling Meng, Jingwen Qiu
  • Publication number: 20100021390
    Abstract: The present invention relates to methods and compositions for the investigation of amyloid formation. In preferred embodiments, amyloid formation associated with type II diabetes is monitored by fluorescence spectroscopic measurements of the activity of p-cyano-phenylalanine-substituted islet amyloid polypeptide, and derivatives thereof, under an amyloid-forming condition. In some embodiments, the amyloid-forming condition is associated with a diseased, or putatively diseased, cell or tissue. In some embodiments, the invention provides a method of evaluating the severity of the amyloid-forming condition, and changes therein induced by agents that inhibit, or potentially inhibit, amyloid formation.
    Type: Application
    Filed: March 17, 2009
    Publication date: January 28, 2010
    Inventors: Daniel P. Raleigh, Andisheh Abedini, Peter Marek, Ruchi Gupta, Fanling Meng